Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults Newswire.ca - Tue May 28, 12:24PM CDT

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 1.0700 (-0.93%)
TCRX : 8.55 (+3.14%)
BMY : 41.09 (+2.09%)
PDSB : 2.98 (+1.02%)
CCCC : 5.00 (+0.40%)
ONC.TO : 1.46 (-0.68%)
Advancements in Cancer Therapeutics: What to Expect from the Upcoming 2024 Oncology Conference BayStreet.ca - Fri May 24, 10:49AM CDT

USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in...

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
MRK : 125.54 (+0.81%)
RHHBY : 32.0100 (+1.39%)
AMGN : 305.85 (+1.61%)
BNTX : 100.60 (+1.87%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 FinancialNewsMedia - Fri May 24, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
RENB : 1.4900 (+1.36%)
CYTO : 1.5300 (+4.08%)
PFE : 28.66 (+1.63%)
ABBV : 161.24 (+3.15%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 GlobeNewswire - Fri May 24, 7:45AM CDT

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
RENB : 1.4900 (+1.36%)
CYTO : 1.5300 (+4.08%)
PFE : 28.66 (+1.63%)
ABBV : 161.24 (+3.15%)
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep’s Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action FinancialNewsMedia - Fri May 24, 7:15AM CDT

Trial-in-progress abstract highlights new cohort that could expand the company’s pancreatic cancer program   Pelareorep’s ability to expand TILs highlights its immunotherapeutic mechanism of action...

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action Newswire.ca - Fri May 24, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two...

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates Newswire.ca - Thu May 23, 10:51AM CDT

/CNW/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic...

ONCY : 1.0700 (-0.93%)
CADL : 8.90 (+3.25%)
AZN : 78.02 (+1.63%)
MRUS : 53.24 (-7.09%)
LTRN : 6.07 (-3.65%)
ONC.TO : 1.46 (-0.68%)
Biotech Developers Pioneer New Treatments, Aiming to Reduce Pancreatic Cancer Fatalities in 2024 BayStreet.ca - Thu May 23, 8:32AM CDT

USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic cancer patients through earlier detection, as according...

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
CADL : 8.90 (+3.25%)
AZN : 78.02 (+1.63%)
MRUS : 53.24 (-7.09%)
LTRN : 6.07 (-3.65%)
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments BayStreet.ca - Fri May 17, 10:48AM CDT

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)
RHHBY : 32.0100 (+1.39%)
MRUS : 53.24 (-7.09%)
MGNX : 4.09 (-3.54%)
IMRX : 1.3900 (+0.72%)
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders Newswire.ca - Thu May 16, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the...

ONCY : 1.0700 (-0.93%)
ONC.TO : 1.46 (-0.68%)

Barchart Exclusives

3 High-yield Dividend Stocks Could Soar 30% Or More Within 12 Months Barchart - Fri May 31, 6:00PM CDT
Discover 3 high-yield dividend stocks that are also highly rated. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot